Theravance Biopharma Inc (TBPH)
9.12
-0.02
(-0.22%)
USD |
NASDAQ |
Apr 26, 16:00
9.112
-0.01
(-0.09%)
After-Hours: 20:00
Theravance Biopharma Price: 9.12 for April 26, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 26, 2024 | 9.13 | 9.27 | 9.06 | 9.12 | 263498.0 |
Apr 25, 2024 | 9.14 | 9.33 | 9.00 | 9.14 | 387247.0 |
Apr 24, 2024 | 9.14 | 9.26 | 9.05 | 9.17 | 297149.0 |
Apr 23, 2024 | 9.45 | 9.61 | 9.19 | 9.22 | 335578.0 |
Apr 22, 2024 | 9.32 | 9.47 | 9.25 | 9.46 | 309740.0 |
Apr 19, 2024 | 9.13 | 9.38 | 9.02 | 9.34 | 433019.0 |
Apr 18, 2024 | 9.51 | 9.52 | 9.15 | 9.20 | 362260.0 |
Apr 17, 2024 | 9.68 | 9.85 | 9.49 | 9.52 | 307877.0 |
Apr 16, 2024 | 9.88 | 9.88 | 9.585 | 9.69 | 472501.0 |
Apr 15, 2024 | 9.53 | 9.98 | 9.488 | 9.92 | 517519.0 |
Apr 12, 2024 | 9.55 | 10.44 | 9.45 | 9.61 | 783427.0 |
Apr 11, 2024 | 9.50 | 9.61 | 8.825 | 8.93 | 472613.0 |
Apr 10, 2024 | 9.35 | 9.55 | 9.18 | 9.54 | 468773.0 |
Apr 09, 2024 | 9.48 | 9.63 | 9.30 | 9.48 | 507606.0 |
Apr 08, 2024 | 9.29 | 9.51 | 9.21 | 9.47 | 371772.0 |
Apr 05, 2024 | 9.14 | 9.33 | 9.05 | 9.31 | 346351.0 |
Apr 04, 2024 | 9.37 | 9.42 | 9.05 | 9.14 | 438871.0 |
Apr 03, 2024 | 9.07 | 9.32 | 9.00 | 9.29 | 476529.0 |
Apr 02, 2024 | 8.93 | 9.12 | 8.79 | 9.10 | 458264.0 |
Apr 01, 2024 | 8.99 | 9.04 | 8.75 | 9.03 | 317724.0 |
Mar 28, 2024 | 9.00 | 9.00 | 8.77 | 8.97 | 401710.0 |
Mar 27, 2024 | 8.85 | 9.02 | 8.79 | 9.01 | 320008.0 |
Mar 26, 2024 | 8.82 | 8.95 | 8.75 | 8.82 | 296175.0 |
Mar 25, 2024 | 8.92 | 9.09 | 8.65 | 8.76 | 365382.0 |
Mar 22, 2024 | 8.95 | 8.98 | 8.83 | 8.92 | 303569.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
6.77
Minimum
Sep 15 2021
31.21
Maximum
Feb 05 2020
14.52
Average
11.24
Median
Dec 29 2022
Price Benchmarks
Corcept Therapeutics Inc | 22.80 |
Nektar Therapeutics | 1.32 |
Vanda Pharmaceuticals Inc | 4.62 |
Fate Therapeutics Inc | 3.80 |
FibroGen Inc | 1.04 |
Price Related Metrics
PS Ratio | 8.788 |
Price to Book Value | 2.062 |
Earnings Yield | -10.64% |
Market Cap | 439.26M |